343 related articles for article (PubMed ID: 26755886)
1. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
Han K; Kim JH; Ko GY; Gwon DI; Sung KB
World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016.
Chan SL; Chong CC; Chan AW; Poon DM; Chok KS
World J Gastroenterol; 2016 Aug; 22(32):7289-300. PubMed ID: 27621575
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.
Minagawa M; Makuuchi M
World J Gastroenterol; 2006 Dec; 12(47):7561-7. PubMed ID: 17171782
[TBL] [Abstract][Full Text] [Related]
4. Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study.
Yu W; Liu W; Zhang K; Chen S; Wang X
Cancer Immunol Immunother; 2023 Nov; 72(11):3609-3619. PubMed ID: 37566127
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.
Cheng S; Yang J; Shen F; Zhou W; Wang Y; Cong W; Yang GS; Cheng H; Hu H; Gao C; Guo J; Li A; Meng Y; Jiang X; Yang Y; Qian G; Luo M; Hu B; Man X; Zhang B; Su C; Zhou F; Li N; Shi J; Wang M; Zheng Y; Guo W; Sun J; Wang H; Lau WY; Wu MC
Oncotarget; 2016 Jun; 7(26):40816-40829. PubMed ID: 27027235
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
Raza A; Sood GK
World J Gastroenterol; 2014 Apr; 20(15):4115-27. PubMed ID: 24764650
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies.
Qi X; Guo X
Prz Gastroenterol; 2015; 10(3):142-7. PubMed ID: 26516379
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.
Yoo SY; Badrinath N; Woo HY; Heo J
Mediators Inflamm; 2017; 2017():5198798. PubMed ID: 28512387
[TBL] [Abstract][Full Text] [Related]
9. Current management of hepatocellular carcinoma: an Eastern perspective.
Yim HJ; Suh SJ; Um SH
World J Gastroenterol; 2015 Apr; 21(13):3826-42. PubMed ID: 25852267
[TBL] [Abstract][Full Text] [Related]
10. Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages.
Titano J; Noor A; Kim E
Semin Intervent Radiol; 2017 Jun; 34(2):109-115. PubMed ID: 28579678
[TBL] [Abstract][Full Text] [Related]
11. Current systemic treatment of hepatocellular carcinoma: A review of the literature.
Chen KW; Ou TM; Hsu CW; Horng CT; Lee CC; Tsai YY; Tsai CC; Liou YS; Yang CC; Hsueh CW; Kuo WH
World J Hepatol; 2015 Jun; 7(10):1412-20. PubMed ID: 26052386
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis.
Chan KM; Lee WC
Biomed J; 2024 Jun; ():100757. PubMed ID: 38942384
[TBL] [Abstract][Full Text] [Related]
13. Portal Vein Thrombosis After Transarterial Embolization for Hepatocellular Carcinoma.
Schwab ME; Decker HC; Monto A; Sawhney R; Corvera CU
JAMA Surg; 2024 Mar; 159(3):345-347. PubMed ID: 38150246
[TBL] [Abstract][Full Text] [Related]
14. Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization: preliminary results.
Pracht M; Edeline J; Lenoir L; Latournerie M; Mesbah H; Audrain O; Rolland Y; Clément B; Raoul JL; Garin E; Boucher E
Int J Hepatol; 2013; 2013():827649. PubMed ID: 23476792
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.
Schütte K; Schulz C; Malfertheiner P
Gastrointest Tumors; 2014 Jun; 1(2):84-92. PubMed ID: 26672483
[TBL] [Abstract][Full Text] [Related]
16. Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma.
Jihye C; Jinsil S
Liver Cancer; 2012 Nov; 1(3-4):216-25. PubMed ID: 24159586
[TBL] [Abstract][Full Text] [Related]
17. Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials.
Rim CH; Yoon WS
Onco Targets Ther; 2018; 11():2865-2874. PubMed ID: 29844684
[TBL] [Abstract][Full Text] [Related]
18. Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review.
Kim D; Kim JS
J Liver Cancer; 2024 Mar; 24(1):33-46. PubMed ID: 38523467
[TBL] [Abstract][Full Text] [Related]
19. Role of Liver Resection for Hepatocellular Carcinoma with Vascular Invasion: Emerging Evidence from Western Countries.
Kokudo N; Kokudo T; Hasegawa K
Liver Cancer; 2021 Sep; 10(5):404-406. PubMed ID: 34721503
[TBL] [Abstract][Full Text] [Related]
20. Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.
Sun Y; Ma W; Yang Y; He M; Li A; Bai L; Yu B; Yu Z
Asian J Pharm Sci; 2019 Nov; 14(6):581-594. PubMed ID: 32104485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
